Rockwell Medical Inc RMTI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RMTI is a good fit for your portfolio.
News
-
Rockwell Medical Named 'Great Place to Work' for Second Year in a Row
-
Rockwell Medical Achieves Profitability on an Adjusted EBITDA Basis in the Fourth Quarter 2023 and Record Net Sales, Gross Profit and Gross Margin for the Full-Year 2023
-
Rockwell Medical to Release Fourth Quarter and Full-Year 2023 Results on Thursday, March 21, 2024
-
Rockwell Medical Amends Loan and Security Agreement with Innovatus Life Sciences Lending Fund
Trading Information
- Previous Close Price
- $1.64
- Day Range
- $1.60–1.64
- 52-Week Range
- $1.16–6.24
- Bid/Ask
- $1.62 / $1.64
- Market Cap
- $47.52 Mil
- Volume/Avg
- 81,233 / 259,738
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.46
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 237
- Website
- https://www.rockwellmed.com
Comparables
Valuation
Metric
|
RMTI
|
MDXG
|
NARI
|
---|---|---|---|
Price/Earnings (Normalized) | — | 80.13 | 509.24 |
Price/Book Value | 2.24 | 7.80 | 5.89 |
Price/Sales | 0.46 | 3.46 | 5.45 |
Price/Cash Flow | — | 20.82 | 80.84 |
Price/Earnings
RMTI
MDXG
NARI
Financial Strength
Metric
|
RMTI
|
MDXG
|
NARI
|
---|---|---|---|
Quick Ratio | 1.31 | 2.95 | 2.43 |
Current Ratio | 1.73 | 3.57 | 3.09 |
Interest Coverage | −2.76 | 5.74 | −56.99 |
Quick Ratio
RMTI
MDXG
NARI
Profitability
Metric
|
RMTI
|
MDXG
|
NARI
|
---|---|---|---|
Return on Assets (Normalized) | −17.02% | 12.48% | 5.07% |
Return on Equity (Normalized) | −49.55% | 123.45% | 6.37% |
Return on Invested Capital (Normalized) | −18.49% | 42.32% | 3.35% |
Return on Assets
RMTI
MDXG
NARI
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Yqfgwvbd | Svfc | $77.2 Bil | |
MKKGY
| Merck KGaA ADR | Shhthfxg | Xnxlb | $75.4 Bil | |
HLN
| Haleon PLC ADR | Kbgrgdmx | Thdz | $38.1 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Vnmygjkj | Twr | $16.0 Bil | |
VTRS
| Viatris Inc | Jgyvvpdc | Xjry | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Zspwfxryz | Hxgp | $12.1 Bil | |
CTLT
| Catalent Inc | Sphkrxz | Gkxphr | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Clyttbgyj | Tlw | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Gjwdpdvl | Dkwvg | $4.0 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Vynsqtns | Wxkmwtx | $3.6 Bil |